(R)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate, 95.0%, 10g

3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE, 95%, 250mg

Ethyl 2-(Trifluoromethyl)nicotinate, 97.0%, 10g

5-(chloromethyl)-3-(4-methoxyphenyl)isoxazole, 95.0%, 250mg

4,5,6,7-Tetrahydro-2-methyl-2H-pyrazolo[4,3-c]pyridine dihydrochloride, 95.0%, 5g

4-Cyclopentylphenol, 95+%, 5g

Acide gallique monohydraté, min 98 %, pa, ACS, 250 g, emballage plastique.

3-Oxo-3H-benzo[f]chromene-2-carboxylic acid, 95+%, 5g

ETHYL 1-(TERT-BUTYL)-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE, 95.0%, 5g

2-Chloro-6-methoxypyridine, 98.0%, 25g

Ethyl 5-oxoheptanoate, 97.0%, 1g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96.0%, 1g

4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-1H-1,2,4-TRIAZOLE-5(4H)-THIONE, 95.0%, 10g